Dr. Deer is the world leader in research, product development, and education in the practice of Interventional Spine and Pain treatment. He is the President and CEO of The Spine and Nerve Centers of the Virginias. He is also a Clinical Professor of Anesthesiology at the West Virginia University School of Medicine.

Tim has been a leader in the field of interventional techniques and neuromodulation for more than two decades.  His rich research career has included many pivotal studies to achieve FDA approval and many “first in man” approved devices. Dr. Deer has provided cadaver based training to over 2000 physicians in novel methods of pain relief without the need for opioids. His work has led to more then 100 peer reviewed publications, several book chapters and full text books. Dr. Deer’s publications have included guidance for the proper use of Neuromodulation to improve safety and efficacy. His text books have included comprehensive guidance on pain, implantable devices and his current project Deer’s Illustrated Guide to the Treatment of Pain has become a text for many of those doing implantable therapies. His new book, Deer’s Treatment of Pain is inclusive of other interventional options as well as the physiology and noninvasive treatment of pain.

Tim has held many national and international society positions including his current roles as the Chairman of the American Society of Pain and Neuroscience Past President of the International Neuromodulation Society (INS) and President Emeritus of the West Virginia Society of Interventional Pain Physicians (WVSIPP). He is the past Chairman of the American Society of Anesthesiologist Committee of Pain Medicine and a Member of the West Virginia Controlled Substance Monitoring Program and has been involved in the peer review process to improve the quality of research in the international arena.

In addition to his many endeavors in Medicine, Tim is an avid ultrarunner completing several 100 mile races, the world’s hardest race, The Badwater 135 and the Florida Keys 50 mile run where he won the male overall championship in 2017. He also has completed over 20 full distance Ironman races, including 6 trips to compete in the Ironman World Championships in Kona, Hawaii.

Dr. Falowski is Director, Functional Neurosurgery St Luke’s University Health Network. He is a board certified Functional Neurosurgeon and with a practice specializing in Neuromodulation.

Steve is Senior Advisor and past Secretary of North American Neuromodulation Society, he is a Board Member International Neuromodulation Society, Board Member Pacific Pain and Spine Society and Secretary and Treasurer Executive Pain Committee. Steve is on the Faculty of the Congress of Neurological Surgeons and of the American Association Neurological Surgeons, he is Executive Officer of the Board, American Society Pain and Neuroscience.

Dr. Hanes is double board-certified in Anesthesiology and Pain Medicine. He is one of the owners of and Chief Medical Officer at Jax Spine & Pain Centers in Jacksonville, FL.

Michael is a published educator and national speaker in the field of interventional pain medicine and is a strong proponent of providing safe, effective and empathetic care options to patients experiencing chronic or acute pain. He started the Centurion Spine Research Institute and is a principal investigator on several research projects focused on minimally invasive spine surgery and neurostimulation. He is a University of Michigan football fan and spends his free time at the gym. He and his wife are members of Our Lady Star of the Sea Catholic Church as well as advocates for the hearing-impaired community. They are dedicated to helping spread awareness of hearing impairment and improving education to those affected by hearing loss.

Dr. Shah is a double-board certified physician specializing in Interventional Pain Medicine and Physical Medicine and Rehabilitation (PM&R/Physiatry), and is the Founder, Chief Physician Executive, and Medical Director of the SamWell Institute for Pain Management in central and northern New Jersey.

Jay completed his training in Interventional Pain Medicine at the prestigious ACGME accredited Weill-Cornell Tri-Institutional Pain Fellowship in NY. There, he trained at three of the nation’s top hospitals: Memorial Sloan Kettering Cancer Center, The Hospital for Special Surgery, and New York Presbyterian Hospital/Weill-Cornell Medical College.

Jay is widely considered a rising star and young physician leader within the field of Pain Medicine. His truly patient-centered, multidisciplinary, and evidence-based approach aims to provide personalized care to each individual patient and their specific needs. Through novel, non-surgical, and minimally invasive interventional techniques, Dr. Shah utilizes the latest technologies to help restore and maximize function as well as overall wellness of patients with chronic musculoskeletal pain related to degenerative conditions and sports-related injuries. This includes non-surgical orthopedic treatments for low back, neck, knee, shoulder, and hip pain as well as pain after neck or back surgeries.

Jay is a strong advocate for evidence-based clinical outcomes and strongly believes in the power of real world clinical outcomes through the Celeri platform.

Dr. Popielarski develops, launches and grows disruptive healthcare solutions. He is currently President and CEO of Thermaquil, Inc. which is developing the world’s first noninvasive and minimally invasive drug-free nerve block devices.

Before founding Thermaquil, Steve got back to his entrepreneurial roots by starting SPHM Enterprises to provide startups and high-growth companies with strategy consulting, marketing training, commercial and operational leadership. This exposure to a wide swath of startups represented a significant change from global marketing with Fortune 50/500 companies where he managed a $2B portfolio of consumer-use medical devices, developed and launched a SaaS business model to drive innovative device adoption, and separately oversaw the launch of a noninvasive neuromodulation system for overactive bladder.

Earlier in his career, Steve was in business development and strategic marketing at molecular diagnostics startup GeneOhm Sciences, which pursued parallel IPO and acquisition paths leading to acquisition for $250M with $5M prior year revenue. Steve has a PhD in Chemical Engineering from Caltech in Pasadena, where his thesis and frequently cited papers uncovered critical parameters for nonviral gene therapy vectors to specifically target hepatocytes in the liver.  His BS is in Materials Science and Engineering from Rensselaer Polytechnic Institute in Troy, NY.

As the Managing Partner, Wasim oversees the overall strategy, investments and partnerships at Iaso Ventures.

He previously served as the first Chief Digital Strategist at Roivant Sciences, a global biopharma company ($7.3B IPO). There he led digital health investments, strategy and partnerships to help accelerate drug development and commercialization across 15+ therapeutic areas, and contributed to incubation and early growth of various portfolio companies.

As part of his work in the healthcare provider industry, Wasim has served on the faculty at Massachusetts General Hospital, the flagship teaching hospital of Harvard Medical School, for over a decade. Affiliated with the MGH Department of Psychiatry and the Clinical Trials Network and Institute, he built a research program on tech-enabled clinical research in neurology, psychiatry and anesthesiology, with a focus on neurodegenerative and movement disorder biomarkers, and brain-computer interfaces.

He serves on the Steering Committee of the NIH EPPIC-Netand IEEE Brain Initiative, the grant review panels for NSF and NASA TRISH, and the national scientific research councils of 6 countries. His work has been featured in multiple media outlets including the Wall Street Journal, New York Times, BBC World, and others.